Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002746

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jan 27, 2016
Accepted (ET)
Mar 29, 2018 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 28, 2017P8,000$2.66A2,168,782ISee footnote
Common StockF3Feb 28, 2017P8,000$2.66A1,642,899D
Common StockF1,F2Mar 27, 2017P2,000$2.68A2,170,782ISee footnote
Common StockF3Mar 27, 2017P2,000$2.68A1,644,899D
Common StockF1,F2Mar 30, 2017P700$2.80A2,171,482ISee footnote
Common StockF3Mar 30, 2017P700$2.80A1,645,599D
Common StockF1,F2Mar 31, 2017P2,000$2.97A2,173,482ISee footnote
Common StockF3Mar 31, 2017P2,000$2.97A1,647,599D
Common StockF1,F2Mar 31, 2017P2,400$3.03A2,175,882ISee footnote
Common StockF3Mar 31, 2017P2,400$3.03A1,649,999D
Common StockF1,F2Apr 4, 2017P600$3.39A2,176,482ISee footnote
Common StockF3Apr 4, 2017P600$3.39A1,650,599D
Common StockF1,F2Apr 5, 2017P600$3.45A2,177,082ISee footnote
Common StockF3Apr 5, 2017P600$3.45A1,651,199D
Common StockF1,F2Apr 12, 2017S200$3.45D2,176,882ISee footnote
Common StockF3Apr 12, 2017S200$3.45D1,650,999D
Common StockF1,F2Apr 13, 2017P100$4.38A2,176,982ISee footnote
Common StockF3Apr 13, 2017P100$4.38A1,651,099D
Common StockF1,F2Apr 17, 2017P200$4.04A2,177,182ISee footnote
Common StockF3Apr 17, 2017P200$4.04A1,651,299D
Common StockF1,F2Oct 18, 2017P20,015$10.46A2,197,197ISee footnote
Common StockF3Oct 18, 2017P20,015$10.46A1,671,314D
Common StockF1,F2Oct 19, 2017P1,300$10.52A2,198,497ISee footnote
Common StockF3Oct 19, 2017P1,300$10.52A1,672,614D
Common StockF1,F2Oct 24, 2017P2,000$10.23A2,200,497ISee footnote
Common StockF3Oct 24, 2017P2,000$10.23A1,674,614D
Common StockF4Feb 28, 2018S26,000$9.26D166,666D
Common StockF1,F2Feb 28, 2018S17,100$9.41D2,183,397ISee footnote
Common StockF1,F2Mar 2, 2018S20,000$9.17D2,163,397ISee footnote
Common StockF1,F2Mar 6, 2018S6,600$9.11D2,156,797ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

This is the third part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.